[Featured Stock] Ray, China Business Expectations... Sales Expected to Increase 53% YoY Next Year '↑'

[Asia Economy Reporter Hyunseok Yoo] Ray is on the rise. It appears that securities firms' analyses, which predict a significant increase in performance due to the full-scale entry into the Chinese market starting next year, have influenced this trend.

As of 9:29 AM on the 29th, Ray was trading at 29,100 KRW, up 2.46% (700 KRW) compared to the previous trading day.

Ray is a specialized company in digital dental medical devices. It sells packages that include CT scanners with scanning functions, CAD/CAM software, and 3D printing equipment.

Sojung Lee, a researcher at SK Securities, stated, "Ray plans to promote overall dental business, including equipment, in the rapidly growing Chinese dental market. On the 16th, Ray invested 28.5 billion KRW in Ray China and plans to enter the dental medical device and software business in China through the establishment of a joint venture with China International Capital Corporation (CICC)."

SK Securities expects sales related to China to increase starting next year. He emphasized, "From 2022, through collaboration with CICC, the growth slope of sales for equipment is expected to steepen. Ray China aims for vertical integration of the dental business by acquiring dental material companies and other dental-related firms, so synergy effects between businesses and external growth are anticipated."

SK Securities forecasted that Ray's sales and operating profit for the fourth quarter of this year will be 28 billion KRW and 6 billion KRW, respectively, representing increases of 34% and 30% compared to the same period last year. Furthermore, sales and operating profit for next year are expected to reach 140 billion KRW and 31 billion KRW, respectively, marking increases of 53% and 97% compared to this year.

This content was produced with the assistance of AI translation services.